TipRanks (Wed, 8-May 9:21 AM ET)
Henry Schein Sell Rating Affirmed Amidst Cybersecurity Woes and Execution Risks
TipRanks (Wed, 8-May 5:27 AM ET)
Henry Schein: Strong Q1 Earnings but Uncertain Outlook Warrants Hold Rating
TipRanks (Tue, 7-May 11:56 PM ET)
Goldman Sachs Sticks to Their Hold Rating for Henry Schein (HSIC)
TipRanks (Tue, 7-May 9:45 PM ET)
Henry Schein Non-GAAP EPS of $1.10 beats by $0.09, revenue of $3.2B in-line
Seeking Alpha News (Tue, 7-May 6:04 AM ET)
Henry Schein Reports Solid First-Quarter 2024 Financial Results and Updates 2024 Financial Guidance
Business Wire (Tue, 7-May 6:00 AM ET)
Notable earnings before Tuesday's open
Seeking Alpha News (Mon, 6-May 11:08 AM ET)
Henry Schein Q1 2024 Earnings Preview
Seeking Alpha News (Mon, 6-May 10:38 AM ET)
Henry Schein to Present at Investor Conferences in May 2024
Business Wire (Mon, 29-Apr 6:30 AM ET)
Henry Schein Medical Announces Winner of Its 2024 Rising Star Award
Business Wire (Tue, 23-Apr 6:30 AM ET)
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Henry Schein trades on the NASDAQ stock market under the symbol HSIC.
As of May 8, 2024, HSIC stock price climbed to $73.04 with 461,697 million shares trading.
HSIC has a beta of 0.53, meaning it tends to be less sensitive to market movements. HSIC has a correlation of 0.09 to the broad based SPY ETF.
HSIC has a market cap of $9.49 billion. This is considered a Mid Cap stock.
Last quarter Henry Schein reported $3 billion in Revenue and $1.10 earnings per share. This fell short of revenue expectation by $-38 million and exceeded earnings estimates by $.09.
In the last 3 years, HSIC stock traded as high as $92.68 and as low as $60.01.
The top ETF exchange traded funds that HSIC belongs to (by Net Assets): VTI, VB, VOO, VBR, SPY.
HSIC has underperformed the market in the last year with a price return of -8.4% while the SPY ETF gained +27.1%. HSIC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.9% and +0.4%, respectively, while the SPY returned +4.2% and +2.4%, respectively.
HSIC support price is $70.23 and resistance is $72.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSIC stock will trade within this expected range on the day.